02 March 2016
SMITHERS AVANZA EXPANDS BIOANALYTICAL LABORATORY
New Space & Increased Capacity Will Support Client Requests for Testing
of Large Molecule Biotherapeutics
GAITHERSBURG, MD, USA – March 2, 2016 – Smithers Avanza, a contract research organization supporting the pharmaceutical industry, announced that its Bioanalytical Services Division has completed an expansion of its bioanalytical laboratory. This expansion will accommodate a 33 percent increase in staff in support of client needs during the development of large molecule biologic therapies.
“Rising demand for testing from our clients, which include some of the world’s largest biopharmaceutical companies, has resulted in the company more than doubling our scientific and support staff year over year,” said Ira DuBey, Executive Vice President, Bioanalytical Services Division, Smithers Avanza. “Expanding our lab space helps us create capacity so that we can continue to support our clients with the highest level of service.”
Following the expansion, the company has already added several new staff members, including senior scientific and support personnel. These new staffers will allow Smithers Avanza to continue to support client development of large molecule biologics including immuno-oncology drugs and combination therapies. Further, the company acquired new liquid handling robotics instrumentation and another Singulex instrument. This equipment will help meet the growing need for testing of high sensitivity biomarker and pharmacokinetic assays.
For more information about the Smithers Avanza portfolio of services, visit www.smithersavanza.com.
# # #
About Smithers Avanza
Smithers Avanza is a contract research organization (CRO) supporting the pharmaceutical industry. Our scientists have expertise in large molecule bioanalysis, assay development, validation and sample analysis at our GLP- and GCP-compliant and CLIA certified laboratory. Smithers Avanza Bioanalytical Services Division supports the development of biologics and vaccines from discovery through phase IV, with expertise that includes bioassays and high sensitivity assays. The services focus primarily on development, validation and sample analysis for PK/TK, ADA, bioassays and biomarker assays. Smithers Avanza also offers preclinical toxicology and vaccine testing at our AAALAC accredited facilities.